Showing results (61-70 of 243) with videos related to

Sort By:
Pageof 25
Anticancer Research|July 31, 2014
Immunohistochemical features associated with sensitivity to lapatinib-plus-capecitabine and resistance to trastuzumab in HER2-positive breast cancerYongjun Cha, Sae-Won Han, Hyesil Seol, et al.
Scientific Reports|July 17, 2021
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOXHye Eun Park, Seung-Yeon Yoo, Nam-Yun Cho, et al.
Oncogene|February 17, 2022
EMT-mediated regulation of CXCL1/5 for resistance to anti-EGFR therapy in colorectal cancerYe-Lim Park, Hwang-Phill Kim, Chan-Young Ock, et al.
Cancer Research and Treatment|November 28, 2018
A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-Line Chemotherapy in Metastatic Colorectal Cancer PatientsYoujin Kim, Tae Won Kim, Sae Won Han, et al.
Annals of Surgical Oncology|August 16, 2015
Impact of Chemotherapy-Induced Ovarian Dysfunction on Response to Neoadjuvant Chemotherapy in Breast CancerSoo Kyung Ahn, Han-Byoel Lee, Wonshik Han, et al.
BMC Cancer|October 25, 2008
The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancerJiyoung Rhee, Sae-Won Han, Do-Youn Oh, et al.
Radiation Oncology Journal|January 25, 2013
Postoperative chemoradiotherapy in high risk locally advanced gastric cancerSanghyuk Song, Eui Kyu Chie, Kyubo Kim, et al.
Cancer Research and Treatment|February 27, 2015
Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid TumorsDo-Youn Oh, Se-Hoon Lee, Sae-Won Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2019
Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and OxaliplatinDae-Won Lee, Sae-Won Han, Jeong Mo Bae, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 4, 2012
Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinomaKyubo Kim, Eui Kyu Chie, Jin-Young Jang, et al.
Pageof 25